SAN DIEGO, Aug. 10, 2023 /PRNewswire/ — Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform today announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company for the Middle East and North…Read More
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox Platform Cancer Treatment in the Middle East and North Africa Hikma Pharmaceuticals OTCHKMPY
